Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

As already predicted there will be no "splash" They will say

1) K is so well tolerated we cannot reach a maximum dose after 3 years of trying, and
2)p21 levels went up in later cohorts

Which will leave all the big questions: does it actually work in patients? what are the right doses to give ?, and how well will K work with other agents?

All of the critical data is unanswered, but we have to say it is safe before we can get the other answers...